Cargando…

Incidence of Pathogenic Variants in Those With a Family History of Pancreatic Cancer

Discovery of a hereditary cancer syndrome can be one of the factors that determine whether a healthy individual completes pancreas cancer screening or whether an individual with cancer receives certain chemotherapies. Retrospective review was completed to determine the likelihood of detection of a p...

Descripción completa

Detalles Bibliográficos
Autores principales:	Macklin, Sarah K., Kasi, Pashtoon M., Jackson, Jessica L., Hines, Stephanie L.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2018
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6110858/ https://www.ncbi.nlm.nih.gov/pubmed/30186770 http://dx.doi.org/10.3389/fonc.2018.00330

Ejemplares similares

Retrospective review of outcomes in patients with DNA-damage repair related pancreatic cancer
por: Macklin-Mantia, Sarah K., et al.
Publicado: (2020)

Editorial: Case reports in gastrointestinal cancers : 2022
por: Kasi, Pashtoon Murtaza
Publicado: (2023)

Circulating Tumor DNA in Identifying Resistant Sub-Clones Post EGFR Blockade: Implications for EGFR Rechallenge
por: Chennamadhavuni, Adithya, et al.
Publicado: (2022)

Role of Circulating Tumor DNA in Gastrointestinal Cancers: Update From Abstracts and Sessions at ASCO 2018
por: Shahjehan, Faisal, et al.
Publicado: (2019)

Patients with pathogenic variants for breast cancer other than BRCA1 and BRCA2: qualitative interviews about health care experiences
por: Clift, Kristin E., et al.
Publicado: (2019)

Adjunctive Use of Circulating Tumor DNA Testing in Detecting Pancreas Cancer Recurrence
por: Soyano, Aixa E., et al.
Publicado: (2019)

Personalized molecular modeling for pinpointing associations of protein dysfunction and variants associated with hereditary cancer syndromes
por: Macklin, Sarah, et al.
Publicado: (2018)

Larotrectinib in Mismatch-Repair-Deficient TRK Fusion-Positive Metastatic Colon Cancer After Progression on Immunotherapy
por: Kasi, Pashtoon M, et al.
Publicado: (2022)

A Care Process Model to Deliver (177)Lu-Dotatate Peptide Receptor Radionuclide Therapy for Patients With Neuroendocrine Tumors
por: Kasi, Pashtoon Murtaza, et al.
Publicado: (2019)

Body Mass Index and Long-Term Outcomes in Patients With Colorectal Cancer
por: Shahjehan, Faisal, et al.
Publicado: (2018)

Clinical Value of Pharmacogenomic Testing in a Patient Receiving FOLFIRINOX for Pancreatic Adenocarcinoma
por: Velez-Velez, Lisa M., et al.
Publicado: (2018)

Circulating Tumor DNA-Based Detection of Microsatellite Instability and Response to Immunotherapy in Pancreatic Cancer
por: Kamatham, Saivaishnavi, et al.
Publicado: (2020)

Late onset asymptomatic pancreatic neuroendocrine tumor – A case report on the phenotypic expansion for MEN1
por: Kaiwar, Charu, et al.
Publicado: (2017)

Factors influencing receptivity to future screening options for pancreatic cancer in those with and without pancreatic cancer family history
por: Breitkopf, Carmen Radecki, et al.
Publicado: (2012)

Impact of Tumor Location and Variables Associated With Overall Survival in Patients With Colorectal Cancer: A Mayo Clinic Colon and Rectal Cancer Registry Study
por: Wang, Cassia B., et al.
Publicado: (2019)

Correlates of Morbidity and Mortality in Severe Necrotizing Pancreatitis
por: Pal, K. M., et al.
Publicado: (2012)

An American patient with polyposis carrying a Scandinavian AXIN2 pathogenic variant
por: Macklin-Mantia, Sarah K., et al.
Publicado: (2020)

The Feasibility and Safety of Surgery in Patients Receiving Immune Checkpoint Inhibitors: A Retrospective Study
por: Elias, Alexandra W., et al.
Publicado: (2017)

Characterization of a Pathogenic Variant in the ABCD1 Gene Through Protein Molecular Modeling
por: Richter Jr., John E., et al.
Publicado: (2020)

Circulating tumour cell enumeration, biomarker analyses, and kinetics in patients with colorectal cancer and other GI malignancies
por: Malkawi, Walla, et al.
Publicado: (2023)

Considerations for Germline Testing in Melanoma: Updates in Behavioral Change and Pancreatic Surveillance for Carriers of CDKN2A Pathogenic Variants
por: Pauley, Kristen, et al.
Publicado: (2022)

Thrombotic Thrombocytopenic Purpura and Gemcitabine
por: Kasi, Pashtoon Murtaza
Publicado: (2011)

Malignant Hyperthermia and Idiopathic HyperCKemia
por: Kasi, Pashtoon Murtaza
Publicado: (2011)

The Use of Intravenous Neostigmine in Palliation of Severe Ileus
por: Kasi, Pashtoon Murtaza
Publicado: (2013)

Favorable Outcomes in FGFR Fusion-Positive Cholangiocarcinomas and Evolution on Treatment Noted on Circulating Tumor DNA Liquid Biopsies
por: Kasi, Pashtoon Murtaza
Publicado: (2020)

Tumor-Informed Versus Plasma-Only Liquid Biopsy Assay in a Patient With Multiple Primary Malignancies
por: Kasi, Pashtoon Murtaza
Publicado: (2022)

Call for Adoption of Synchronized Biweekly Dosing of Anti-EGFR Agent Cetuximab: Implications for Patients with Metastatic Colorectal Cancer, and Squamous Cell Carcinoma of the Head and Neck
por: Kasi, Pashtoon Murtaza
Publicado: (2022)

Types of Liquid Biopsies: Understanding the Different Lenses Through Which They Can Detect Cancer
por: Kasi, Pashtoon Murtaza
Publicado: (2023)

BESPOKE IO protocol: a multicentre, prospective observational study evaluating the utility of ctDNA in guiding immunotherapy in patients with advanced solid tumours
por: Kasi, Pashtoon Murtaza, et al.
Publicado: (2022)

Comparison of a Focused Family Cancer History Questionnaire to Family History Documentation in the Electronic Medical Record
por: Clift, Kristin, et al.
Publicado: (2022)

Clinically relevant combined effect of polygenic background, rare pathogenic germline variants, and family history on colorectal cancer incidence
por: Hassanin, Emadeldin, et al.
Publicado: (2023)

Family History of Cancer in Benign Brain Tumor Subtypes Versus Gliomas
por: Ostrom, Quinn T., et al.
Publicado: (2012)

Incidence of bifid pancreatic duct in pancreaticoduodenectomy and its impact on clinically relevant postoperative pancreatic fistula
por: Ouyang, Liu, et al.
Publicado: (2022)

A Phase II Trial of Adjuvant Durvalumab Following Trimodality Therapy for Locally Advanced Esophageal and Gastroesophageal Junction Adenocarcinoma: A Big Ten Cancer Research Consortium Study
por: Mamdani, Hirva, et al.
Publicado: (2021)

Family History and Risk of Upper Gastrointestinal Cancer in the Linxian General Population
por: Yang, Huan, et al.
Publicado: (2021)

Incidence and outcome of immune checkpoint-induced pneumonitis in oncology patients with history of pulmonary disease
por: Allen, Emily, et al.
Publicado: (2023)

Rituximab and Cytokine Release Syndrome
por: Kulkarni, Hrishikesh S., et al.
Publicado: (2012)

Exceptional response to everolimus in a novel tuberous sclerosis complex-2 mutation–associated metastatic renal-cell carcinoma
por: Alsidawi, Samer, et al.
Publicado: (2018)

Whole exome sequencing identified a novel POT1 variant as a candidate pathogenic allele underlying a Li–Fraumeni-like family
por: Li, Yuping, et al.
Publicado: (2022)

Incidence, Management, and Outcome of Molar Pregnancies at a Tertiary Care Hospital in Quetta, Pakistan
por: Fatima, Mahrukh, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_9b2lfe2ombbijgm7kbliu1mshr